Clinical Trials Directory

Trials / Sponsors / GW Pharmaceuticals Ltd

GW Pharmaceuticals Ltd

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Ren
Renal Insufficiency, Kidney Disease
Phase 12016-01-01
WithdrawnA Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer
Advanced Cancer
Phase 12015-10-01
TerminatedA Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses
Healthy Volunteers
Phase 12014-08-01
TerminatedA Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
Head and Neck Squamous Cell Carcinoma
Phase 12014-02-01
CompletedSativex® for Relieving Persistent Pain in Participants With Advanced Cancer
Pain, Advanced Cancer
Phase 32010-11-25
CompletedA Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
Palliative Care, Pain, Cancer
Phase 22007-11-01
CompletedSativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
Multiple Sclerosis
Phase 32006-09-01